Cleared Traditional

K921322 - MORSE ANESTHESIA MANIFOLD

K921322 is the FDA 510(k) clearance for MORSE ANESTHESIA MANIFOLD by Namic. It is a Class 2 General Hospital device (product code FPA) cleared through the Traditional 510(k) pathway after a 484-day FDA review.

K921322 · Namic · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1993
Decision
484d
Days
Class 2
Risk

K921322 is an FDA 510(k) clearance for the MORSE ANESTHESIA MANIFOLD. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Namic (Glens Falls, US). The FDA issued a Cleared decision on July 9, 1993 after a review of 484 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General Hospital submissions.

View all Namic devices

Submission Details

510(k) Number K921322 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 12, 1992
Decision Date July 09, 1993
Days to Decision 484 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
355d slower than avg
Panel avg: 129d · This submission: 484d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 481
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K921322.
BARD AMBU PUMP SPIK TUB SET PACRET PROVID PUMP SET
K925058 · C.R. Bard, Inc. · Aug 1993
IVAC 59 SERIES UNIVERSAL SET W/ ANTI-FREE FLOW VAL
K925228 · Y · Jul 1993
BAXTER SOLUTION ADMINISTRATION SETS
K924721 · Baxter Healthcare Corp · Jul 1993
SHROUDED NEEDLE DEVICES
K924718 · Imed Corp. · Jun 1993
INTERLINK(TM) INJECTION SITE
K925126 · Baxter Healthcare Corp · Jun 1993
AVI(TM) MODEL 232 STANDARD IV ADMINISTRATION SET
K924207 · 3M Health Care, Ltd. · May 1993